Mirvie is dedicated to shaping the future of pregnancy health

Mirvie is shaping the future of pregnancy health by providing women and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.

The Future of Pregnancy Health Starts Here

One in five pregnancies is impacted by complications.

The Mirvie RNA platform has the power to predict them before they happen123 enabling proactive, preventive, and personalized pregnancy care for the well-being of millions of moms and babies.

The idea for Mirvie was sparked by the personal experience of one of the founders whose daughter was born prematurely.

Mirvie’s world-class team of scientists and entrepreneurs.

Mirvie’s team members have brought to market category-first, non-invasive tests in both women’s health and in early cancer detection, used by millions today.

Mirvie is backed by early-stage financing from top-tier investors.

Khosla Ventures
Mayfield Investors Logo
Foresite Capital Logo
Funds and
Accounts
managed by
General Catalyst

INVESTORS

Interested in helping us shape the future of pregnancy health?

We want to hear from you!